Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications (2020)
Source: DARU Journal of Pharmaceutical Sciences. Unidade: IQSC
Assunto: PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASERI, Rozita et al. Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications. DARU Journal of Pharmaceutical Sciences, v. 28, p. 333–358, 2020Tradução . . Disponível em: https://doi.org/10.1007/s40199-020-00327-y. Acesso em: 23 maio 2024.APA
Naseri, R., Navabi, S. J., Samimi, Z., Mishra, A. P., Nigam, M., Chandra, H., et al. (2020). Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications. DARU Journal of Pharmaceutical Sciences, 28, 333–358. doi:10.1007/s40199-020-00327-yNLM
Naseri R, Navabi SJ, Samimi Z, Mishra AP, Nigam M, Chandra H, Olatunde A, Tijjani H, Urano RP de M, Farzaei MH. Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications [Internet]. DARU Journal of Pharmaceutical Sciences. 2020 ; 28 333–358.[citado 2024 maio 23 ] Available from: https://doi.org/10.1007/s40199-020-00327-yVancouver
Naseri R, Navabi SJ, Samimi Z, Mishra AP, Nigam M, Chandra H, Olatunde A, Tijjani H, Urano RP de M, Farzaei MH. Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications [Internet]. DARU Journal of Pharmaceutical Sciences. 2020 ; 28 333–358.[citado 2024 maio 23 ] Available from: https://doi.org/10.1007/s40199-020-00327-y
